Antiviral effects of quinine sulfate on HSV-1 HaCat cells infected: analysis of the molecular mechanisms involved.
Baroni
A
A
Paoletti
I
I
Ruocco
E
E
Ayala
F
F
Corrado
F
F
Wolf
R
R
Tufano
M A
MA
Donnarumma
G
G
D000818:Animals; D000962:Antimalarials / Q000494:pharmacology*; D000998:Antiviral Agents / Q000494:pharmacology*; D045744:Cell Line, Tumor; D002522:Chlorocebus aethiops; D018840:HSP70 Heat-Shock Proteins / Q000096:biosynthesis; D017405:Herpes Simplex Virus Protein Vmw65 / Q000096:biosynthesis; D018259:Herpesvirus 1, Human / Q000378:metabolism*; D006801:Humans; D017874:Immediate-Early Proteins / Q000096:biosynthesis; D016328:NF-kappa B / Q000378:metabolism; D011803:Quinine / Q000494:pharmacology*; D014709:Vero Cells; D014779:Virus Replication / Q000187:drug effects
D000962:Antimalarials; D000998:Antiviral Agents; D018840:HSP70 Heat-Shock Proteins; D017405:Herpes Simplex Virus Protein Vmw65; C057120:ICP27 protein, human herpesvirus 1; D017874:Immediate-Early Proteins; D016328:NF-kappa B; D011803:Quinine